We are improving our search experience. To check which content you have full access to, or for advanced search, go back to the old search.

Search

Please fill in this field.

Search Results

Showing 1-20 of 682 results
  1. Empagliflozin improves insulin sensitivity in patients with recent acute coronary syndrome and newly detected dysglycaemia

    Background

    Empagliflozin reduces the risk of cardiovascular disease (CVD) in patients with type 2 diabetes (T2DM) and high cardiovascular risk via...

    Elena Fortin, Magnus Lundin, ... Giulia Ferrannini in Cardiovascular Diabetology
    Article Open access 11 August 2023
  2. Advanced glycation end-products and its soluble receptor are not independent predictors of incident dysglycaemia or metabolic syndrome in women with polycystic ovary syndrome: a prospective observational study

    Background

    To evaluate the association of serum advanced glycation end-products (AGEs) and its soluble receptor of AGE (sRAGE) levels with...

    Yu Wing Tong, Jennifer Ka Yee Ko, ... Raymond Hang Wun Li in Reproductive Biology and Endocrinology
    Article Open access 10 May 2023
  3. Targeted proteomics identifies potential biomarkers of dysglycaemia, beta cell function and insulin sensitivity in Black African men and women

    Aims/hypothesis

    Using a targeted proteomics approach, we aimed to identify and validate circulating proteins associated with impaired glucose...

    Amy E. Mendham, Lisa K. Micklesfield, ... Julia H. Goedecke in Diabetologia
    Article 17 September 2022
  4. On the causal relationships between hyperinsulinaemia, insulin resistance, obesity and dysglycaemia in type 2 diabetes

    Hundreds of millions of people are affected by hyperinsulinaemia, insulin resistance, obesity and the dysglycaemia that mark a common progression...

    James D. Johnson in Diabetologia
    Article 22 July 2021
  5. Gender differences in screening for glucose perturbations, cardiovascular risk factor management and prognosis in patients with dysglycaemia and coronary artery disease: results from the ESC-EORP EUROASPIRE surveys

    Background

    Gender disparities in the management of dysglycaemia, defined as either impaired glucose tolerance (IGT) or type 2 diabetes (T2DM), in...

    Giulia Ferrannini, Dirk De Bacquer, ... Lars Rydén in Cardiovascular Diabetology
    Article Open access 11 February 2021
  6. Zinc-alpha2-glycoprotein, dysglycaemia and insulin resistance: a systematic review and meta-analysis

    To systematically review the current literature investigating associations between zinc-alpha2-glycoprotein (ZAG) and dysglycaemia (including type 2...

    Harriet M. Pearsey, Joseph Henson, ... Thomas E. Yates in Reviews in Endocrine and Metabolic Disorders
    Article Open access 07 May 2020
  7. Comparison of neurocognitive changes among newly diagnosed tuberculosis patients with and without dysglycaemia

    Background

    Diabetes often occurs together with tuberculosis (TB) and both may affect each other negatively. Diabetes may be associated with...

    Ernest Yorke, Vincent Boima, ... C. Charles Mate-Kole in BMC Psychiatry
    Article Open access 03 April 2020
  8. Cardiometabolic risk factors correlated with the incidence of dysglycaemia in a Brazilian normoglycaemic sample: the Baependi Heart Study cohort

    Background

    Dysglycaemia is defined by elevated glucose levels in the blood, commonly characterized by impaired fasting glucose, impaired glucose...

    Camila Maciel De Oliveira, Luciane Viater Tureck, ... Alexandre C. Pereira in Diabetology & Metabolic Syndrome
    Article Open access 13 January 2020
  9. Practical Guide to Glucocorticoid Induced Hyperglycaemia and Diabetes

    Glucocorticoids, also known as steroids, are a class of anti-inflammatory drugs utilised widely in clinical practice for a variety of conditions....

    Hannah L. Barker, Deborah Morrison, ... Gregory C. Jones in Diabetes Therapy
    Article Open access 24 March 2023
  10. Prevalence of atherosclerosis in individuals with prediabetes and diabetes compared to normoglycaemic individuals—a Swedish population-based study

    Background

    Patients with type 2 diabetes have an increased risk of death and cardiovascular events and people with diabetes or prediabetes have been...

    Carl Johan Östgren, Julia Otten, ... Johan Sundström in Cardiovascular Diabetology
    Article Open access 27 September 2023
  11. Advances in diabetes technology to improve the lives of people with cystic fibrosis

    People with cystic fibrosis (CF) are at risk for dysglycaemia caused by progressive beta cell dysfunction and destruction due to pancreatic exocrine...

    Kevin J. Scully, Brynn E. Marks, Melissa S. Putman in Diabetologia
    Article 12 July 2024
  12. Early beta cell dysfunction vs insulin hypersecretion as the primary event in the pathogenesis of dysglycaemia

    Obesity and insulin resistance are associated with the development of type 2 diabetes. It is well accepted that beta cell dysfunction is required for...

    Nathalie Esser, Kristina M. Utzschneider, Steven E. Kahn in Diabetologia
    Article 07 September 2020
  13. Metabolomic signatures for visceral adiposity and dysglycaemia in Asian Chinese and Caucasian European adults: the cross-sectional TOFI_Asia study

    Background

    Asian Chinese are more susceptible to deposition of visceral adipose tissue (VAT) and type 2 diabetes (T2D) development than European...

    Zhanxuan E. Wu, Karl Fraser, ... Sally D. Poppitt in Nutrition & Metabolism
    Article Open access 16 November 2020
  14. Glycaemia risk index uncovers distinct glycaemic variability patterns associated with remission status in type 1 diabetes

    Aims/hypothesis

    The aim of this work was to define a unique remission status using glycaemia risk index (GRI) and other continuous glucose monitoring...

    Ting Zhong, Binbin He, ... **a Li in Diabetologia
    Article 27 October 2023
  15. Mannose-binding lectin does not explain the dismal prognosis after an acute coronary event in dysglycaemic patients. A report from the GAMI cohort

    Background

    Mannose binding lectin (MBL) has been suggested to be associated with an impaired cardiovascular prognosis in dysglycaemic conditions, but...

    Sara Meziani, Giulia Ferrannini, ... Linda G. Mellbin in Cardiovascular Diabetology
    Article Open access 08 July 2022
  16. Gestational glucose intolerance among pregnant women at the Cape Coast Teaching Hospital

    Background

    Malaria in pregnancy can have adverse outcomes if untreated. Both malaria and pregnancy are associated with insulin resistance and...

    Nelson Ekow Kumah, Evans Kofi Agbeno, ... Samuel Acquah in BMC Pregnancy and Childbirth
    Article Open access 14 May 2024
  17. Deteriorating beta cell function is the dominant determinant of progression from normal glucose tolerance to prediabetes/diabetes in young women following pregnancy

    Aims/hypothesis

    Excess adiposity, insulin resistance and beta cell dysfunction each contribute to the development of prediabetes (impaired glucose...

    Ravi Retnakaran, Chang Ye, ... Bernard Zinman in Diabetologia
    Article 24 August 2023
Did you find what you were looking for? Share feedback.